Artivion (AORT) Stock Forecast, Price & News

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Artivion in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" AORT shares.
View AORT analyst ratings or view top-rated stocks.

4 Wall Street analysts have issued 1 year price objectives for Artivion's shares. Their AORT share price forecasts range from $14.00 to $28.00. On average, they expect the company's share price to reach $23.25 in the next year. This suggests a possible upside of 54.6% from the stock's current price.
View analysts price targets for AORT or view top-rated stocks among Wall Street analysts.

Artivion's stock was trading at $12.12 at the start of the year. Since then, AORT shares have increased by 24.1% and is now trading at $15.04.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023.
View our AORT earnings forecast.

Artivion, Inc. (NYSE:AORT) issued its quarterly earnings data on Thursday, August, 3rd. The company reported $0.06 EPS for the quarter, beating the consensus estimate of $0.01 by $0.05. The firm had revenue of $89.25 million for the quarter, compared to analyst estimates of $84.45 million. Artivion had a positive trailing twelve-month return on equity of 1.97% and a negative net margin of 8.66%.

Artivion issued an update on its FY 2023 earnings guidance on Thursday, August, 3rd. The company provided EPS guidance of for the period. The company issued revenue guidance of $342.00 million-$350.00 million, compared to the consensus revenue estimate of $340.69 million.

Artivion trades on the New York Stock Exchange (NYSE) under the ticker symbol "AORT."

Artivion's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (17.26%), State Street Corp (3.92%), Dimensional Fund Advisors LP (3.56%), Royce & Associates LP (2.32%), Perceptive Advisors LLC (2.27%) and Wasatch Advisors LP (1.98%). Insiders that own company stock include Amy Horton, Andrew M Green, David Ashley Lee, Dennis B Maier, James P Mackin, Matthew A Getz and Rochelle L Maney.
View institutional ownership trends.

Shares of AORT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of AORT stock can currently be purchased for approximately $15.04.

Artivion (NYSE:AORT) has a market capitalization of $617.24 million and generates $313.79 million in revenue each year. The company earns $-19,190,000.00 in net income (profit) each year or ($0.70) on an earnings per share basis.

The company employs 1,300 workers across the globe.

Artivion's mailing address is 1655 Roberts Blvd NW, Kennesaw, Georgia 30144-3632. The official website for the company is www.cryolife.com. The company can be reached via phone at (770) 419-3355, via email at investors@cryolife.com, or via fax at 770-426-0031.